Normally, I don’t write about this kind of stuff, however, I thought I’d pass this on. Genentech is doing clinical trials and needs folks with Rheumatoid Arthritis. I do not know anything about the study and am not affiliated with the organization. Please read the following and visit the website, then draw your own conclusions about participating. You may contact Stephanie at: firstname.lastname@example.org if you have any questions.
Here is the information:
My name is Stephanie Holbrook and I am contacting you on behalf of Genentech, a leading biotech company, with multiple products on the market for serious or life-threatening medical conditions. I wanted to inform you about three clinical trials that are taking place at more than 200 U.S. medical facilities, nationwide. Researchers are currently enrolling patients in three rheumatoid arthritis clinical trials for an investigational drug, rituximab. Those who are between 18 and 80 years old and suffer from active rheumatoid arthritis may qualify for one of these trials.
Please consider informing your audience about these three rheumatoid arthritis clinical trials, by featuring this information on Chronic Life. For more information on these trials, visit http://www.studyra.com. StudyRA.com provides information about each of the three individual trials, as well as inclusion and exclusion criteria used to help identify appropriate participants. Your audience members can see if they may qualify to participate by taking an online survey (http://t.pollg.com/o25863.htm ) to assess their eligibility for the trials or by calling 1-888-82-STUDY (78839) to talk to a representative. The survey only takes about 10 minutes to complete. Please feel free to feature any information from StudyRA.com on your site.